Literature DB >> 7894223

Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus.

J Collazos1, E Martínez, M Flores, J Mayo.   

Abstract

The case of a patient with systemic lupus erythematosus who developed pneumonia caused by Aspergillus fumigatus is described. She was treated with itraconazole 200 mg twice daily, with a rapid response. After a follow-up period of 5 years no recurrence of the infection has been detected. To our knowledge this is the first report on the use of itraconazole in patients with systemic lupus erythematosus. Considering the poor prognosis associated with Aspergillus pneumonia in patients with systemic lupus erythematosus, we believe that itraconazole constitutes a safe and effective alternative to amphotericin B in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894223     DOI: 10.1007/bf00190752

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  10 in total

1.  Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis.

Authors:  M Kimura; S Udagawa; A Shoji; H Kume; M Iimori; T Satou; S Hashimoto
Journal:  Mycopathologia       Date:  1990-07       Impact factor: 2.574

Review 2.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

Authors:  D W Denning; D A Stevens
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

Review 3.  Treatment of opportunistic fungal infections.

Authors:  D Armstrong
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

4.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

Review 5.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

7.  Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

Authors:  D B Hellmann; M Petri; Q Whiting-O'Keefe
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

8.  [Infection in systemic lupus erythematosus].

Authors:  J Juega; J D Pedreira; M Adega; F Valdés; A Echaniz
Journal:  Rev Clin Esp       Date:  1989-03       Impact factor: 1.556

9.  Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group.

Authors:  O Nived; G Sturfelt; F Wollheim
Journal:  Q J Med       Date:  1985-06

Review 10.  Azole antifungal agents.

Authors:  G P Bodey
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.